Morgan Stanley’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $134M | Buy |
2,428,689
+1,385,804
| +133% | +$76.2M | 0.01% | 1120 |
|
2025
Q1 | $73.7M | Sell |
1,042,885
-297,547
| -22% | -$21M | 0.01% | 1481 |
|
2024
Q4 | $88.1M | Buy |
1,340,432
+470,208
| +54% | +$30.9M | 0.01% | 1354 |
|
2024
Q3 | $61.2M | Sell |
870,224
-326,539
| -27% | -$23M | ﹤0.01% | 1646 |
|
2024
Q2 | $98.5M | Buy |
1,196,763
+186,514
| +18% | +$15.4M | 0.01% | 1188 |
|
2024
Q1 | $88.2M | Sell |
1,010,249
-870,495
| -46% | -$76M | 0.01% | 1285 |
|
2023
Q4 | $181M | Buy |
1,880,744
+1,119,237
| +147% | +$108M | 0.01% | 1224 |
|
2023
Q3 | $67.4M | Sell |
761,507
-124,714
| -14% | -$11M | 0.01% | 1325 |
|
2023
Q2 | $76.8M | Sell |
886,221
-2,262
| -0.3% | -$196K | 0.01% | 1255 |
|
2023
Q1 | $86.4M | Sell |
888,483
-206,873
| -19% | -$20.1M | 0.01% | 1150 |
|
2022
Q4 | $113M | Buy |
1,095,356
+276,841
| +34% | +$28.7M | 0.01% | 954 |
|
2022
Q3 | $69.4M | Sell |
818,515
-225,802
| -22% | -$19.1M | 0.01% | 1104 |
|
2022
Q2 | $86.5M | Buy |
1,044,317
+391,301
| +60% | +$32.4M | 0.01% | 1019 |
|
2022
Q1 | $50.3M | Buy |
653,016
+222,564
| +52% | +$17.2M | 0.01% | 1305 |
|
2021
Q4 | $38M | Sell |
430,452
-327,622
| -43% | -$28.9M | ﹤0.01% | 1547 |
|
2021
Q3 | $58.6M | Buy |
758,074
+17,576
| +2% | +$1.36M | 0.01% | 1188 |
|
2021
Q2 | $61.8M | Sell |
740,498
-40,727
| -5% | -$3.4M | 0.01% | 1163 |
|
2021
Q1 | $59M | Buy |
781,225
+120,926
| +18% | +$9.13M | 0.01% | 1055 |
|
2020
Q4 | $57.9M | Buy |
660,299
+139,166
| +27% | +$12.2M | 0.01% | 988 |
|
2020
Q3 | $39.6M | Sell |
521,133
-51,593
| -9% | -$3.93M | 0.01% | 1034 |
|
2020
Q2 | $70.6M | Buy |
572,726
+25,986
| +5% | +$3.21M | 0.02% | 688 |
|
2020
Q1 | $46.2M | Buy |
546,740
+88,791
| +19% | +$7.5M | 0.01% | 775 |
|
2019
Q4 | $38.7M | Sell |
457,949
-13,530
| -3% | -$1.14M | 0.01% | 1112 |
|
2019
Q3 | $31.8M | Sell |
471,479
-85,137
| -15% | -$5.74M | 0.01% | 1138 |
|
2019
Q2 | $47.7M | Buy |
556,616
+217,847
| +64% | +$18.7M | 0.01% | 876 |
|
2019
Q1 | $30.1M | Sell |
338,769
-257,205
| -43% | -$22.8M | 0.01% | 1141 |
|
2018
Q4 | $50.7M | Buy |
595,974
+150,165
| +34% | +$12.8M | 0.02% | 811 |
|
2018
Q3 | $43.2M | Sell |
445,809
-141,367
| -24% | -$13.7M | 0.01% | 1045 |
|
2018
Q2 | $55.3M | Buy |
587,176
+123,430
| +27% | +$11.6M | 0.01% | 858 |
|
2018
Q1 | $37.6M | Sell |
463,746
-9,018
| -2% | -$731K | 0.01% | 1116 |
|
2017
Q4 | $42.2M | Buy |
472,764
+49,096
| +12% | +$4.38M | 0.01% | 1069 |
|
2017
Q3 | $39.4M | Sell |
423,668
-35,600
| -8% | -$3.31M | 0.01% | 1054 |
|
2017
Q2 | $41.7M | Buy |
459,268
+52,008
| +13% | +$4.72M | 0.01% | 1013 |
|
2017
Q1 | $35.8M | Buy |
407,260
+36,286
| +10% | +$3.19M | 0.01% | 1121 |
|
2016
Q4 | $30.7M | Sell |
370,974
-31,668
| -8% | -$2.62M | 0.01% | 1184 |
|
2016
Q3 | $37.3M | Buy |
402,642
+84,868
| +27% | +$7.85M | 0.01% | 1030 |
|
2016
Q2 | $24.7M | Sell |
317,774
-49,665
| -14% | -$3.86M | 0.01% | 1258 |
|
2016
Q1 | $30.3M | Buy |
367,439
+127,720
| +53% | +$10.5M | 0.01% | 1049 |
|
2015
Q4 | $25.1M | Sell |
239,719
-124,174
| -34% | -$13M | 0.01% | 1239 |
|
2015
Q3 | $38.3M | Buy |
363,893
+83,877
| +30% | +$8.83M | 0.01% | 946 |
|
2015
Q2 | $38.3M | Sell |
280,016
-54,482
| -16% | -$7.45M | 0.01% | 1019 |
|
2015
Q1 | $41.7M | Sell |
334,498
-22,419
| -6% | -$2.79M | 0.02% | 956 |
|
2014
Q4 | $32.3M | Sell |
356,917
-116,677
| -25% | -$10.5M | 0.01% | 1123 |
|
2014
Q3 | $34.2M | Buy |
473,594
+80,616
| +21% | +$5.82M | 0.01% | 1044 |
|
2014
Q2 | $24.4M | Buy |
392,978
+40,624
| +12% | +$2.53M | 0.01% | 1257 |
|
2014
Q1 | $24M | Sell |
352,354
-26,875
| -7% | -$1.83M | 0.01% | 1229 |
|
2013
Q4 | $26.7M | Buy |
379,229
+41,310
| +12% | +$2.91M | 0.01% | 1133 |
|
2013
Q3 | $24.4M | Buy |
337,919
+218,397
| +183% | +$15.8M | 0.01% | 1077 |
|
2013
Q2 | $6.66M | Buy |
+119,522
| New | +$6.66M | ﹤0.01% | 2063 |
|